Phygen
Irvine, US · Delaware LLC
Founders & leadership
MS
Mark SelawskiNamed on SEC filing
AD
Amir David TaherniaManager
BG
Ben GuiotManager
TG
Thomas GardnerManager
LK
Lee KelleyManager
FK
Frank KuwamuraManager
MR
Mark RenfroManager
TK
Tom KulaManager
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 of 2 rounds · 2018
▶Undisclosed amountofferedMay 2018 · BiotechnologyRule 506(b)
▶Undisclosed amountofferedMay 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tom KulaDirector
- Amir David TaherniaDirector
- Thomas GardnerExecutive Officer, Director
- Lee KelleyDirector
- Mark RenfroDirector
- Ben GuiotDirector
- Frank KuwamuraDirector
- Mark SelawskiExecutive Officer
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2MraisedApr 2018 · 1 investors · BiotechnologyRule 506(b)
▶$2MraisedApr 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amir David TaherniaDirector
- Ben GuiotDirector
- Thomas GardnerExecutive Officer, Director
- Lee KelleyDirector
- Frank KuwamuraDirector
- Mark RenfroDirector
- Tom KulaDirector
- Mark SelawskiExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Apr 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Phygen raised?
- Phygen has disclosed $2M raised across 1 of its 2 known rounds.
- Where is Phygen headquartered?
- Phygen is headquartered in Irvine, US.